Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers Proxima, a cloud-based platform to store, analyze, and share spatial data; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.
Earnings for Akoya Biosciences, Inc. (AKYA)
Earnings in 2023 (TTM): $-63,283,000
According to Akoya Biosciences, Inc.'s latest financial reports the company's current earnings (TTM) are $-63,283,000. The earnings displayed on this page is the company's Pretax Income.
Earnings history of Akoya Biosciences, Inc.
Annual Earnings
| Year | Income Before Tax | Net Income |
|---|---|---|
| 2023 | $-63,283,000 | $-63,323,000 |
| 2022 | $-70,518,000 | $-70,641,000 |
| 2021 | $-43,075,000 | $-42,935,000 |
| 2020 | $-16,664,000 | $-16,706,000 |
| 2019 | $-14,557,000 | $-14,751,000 |